Aspirin fails pregnancy test
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.THE LARGEST study of the effects of low dose aspirin on pregnant women shows it has failed to make its expected impact on a common and dangerous complication of pregnancy, writes Celia Hall.
Pre-eclampsia can threaten the life of the mother and her baby, causing very high blood pressure, swelling and kidney damage. It affects more than 50,000 pregnant women a year in Britain. Small studies had suggested that very low dose aspirin might reduce cases by half.
But a study of 9,364 women in 16 countries, reported in tomorrow's Lancet, shows low dose aspirin only reduces the risk of pre-eclampsia by about 25 per cent, with no clear benefit to the baby. The researchers conclude aspirin might still be useful for women who get the symptoms early in pregnancy.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments